SCHEMBL5652789

SCHEMBL5652789

Cc1ccc2c(c1)c(O)c(C(=O)NC1CCCCC1)c(=O)n2-c1ccc(F)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
ALDH1A1 P00352 1/20 0.53
HPGD P15428 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
GAA P10253 1/20 0.51
PPARG P37231 1/20 0.51
NCOA2 Q15596 1/20 0.51
HTR3E A5X5Y0 1/20 0.50
HTR3B O95264 1/20 0.50
HTR3A P46098 1/20 0.50
HTR3D Q70Z44 1/20 0.50
HTR3C Q8WXA8 1/20 0.50
CNR1 P21554 13/20 0.47
CNR2 P34972 12/20 0.47
FAAH O00519 6/20 0.47
ABHD12 Q8N2K0 3/20 0.45
TAS1R3 Q7RTX0 2/20 0.43
TAS1R1 Q7RTX1 2/20 0.43
TAS1R2 Q8TE23 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5534556 0.84 CNR2 (0.58) CNR1CNR2FAAHABHD12
SCHEMBL5528757 0.82 NPC1 (0.73) NPC1RAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL5524624 0.79 NPC1 (0.72) NPC1RAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL5526109 0.76 CNR1 (0.64) NPC1RAB9AGAAPPARGNCOA2
SCHEMBL5527487 0.75 CNR2 (0.60) CNR1CNR2FAAHABHD12
SCHEMBL5530075 0.72 CNR2 (0.64) NPC1RAB9AGAAPPARGNCOA2
SCHEMBL14376426 0.71 NPC1 (0.72) NPC1RAB9AALDH1A1HPGDGAA
SCHEMBL5529629 0.70 NPC1 (0.71) NPC1RAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL5527500 0.69 CNR2 (0.65) NPC1RAB9AGAAPPARGNCOA2
SCHEMBL24937540 0.69 CNR1 (0.85) CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070054923-A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same AVANIR PHARMACEUTICALS 2007-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070054923-A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same MIF, MSR1, MMP12 NPC1 705/4885RAB9A 2899/4885ALDH1A1 1799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.